Debbie Stephens Ledet

About Debbie Stephens Ledet

25 year Executive leader and Investor partner driving Market Access, Government Affairs, AI, Software-as-a-Service (SaaS), Molecular Diagnostics, Medical Devices and other new disruptive healthcare technologies. Successfully secure CPT codes, reimbursement, medical policy coverage, commercial & governmental contracts. Strong \"hands-on\" background in Market Access, Management, Sales, Field Reimbursement, Market Access Marketing, Strategic Accounts, Public Sector, Health Plans, GPOs, Business Development. Investor Advisor leading to successful IPOs, Mergers & Acquisitions strategic investment rounds, investment strategy, emerging growth, Series C, ROI.Key areas of focus: AI, SaaS, Women\'s health, oncology, start-ups, go-to-market, Molecular Diagnostics, biotech, Next Generation Sequencing, SNPs, patient advocacy, CPT, government & national accounts, GPOs, ACOs, C-Suites, P&L, due diligence, data rooms, acquisitions, Board of Directors Advisor, Specialty Society, KOL relations, public health, team building, training, Laboratory, Hospital, Physicians, Outpatient, IDTF.Changing the standard of care w/innovative diagnostics / devices / personalized medicine driving reimbursement & utilization of revolutionary medical technologies / creating Patient access & Physician demand. Specialties: Software-as-a-Service, Oncology, Obstetrics & Gynecology, Prenatal, Molecular Lab Diagnostics, STD Testing, CV, Neuro, Renal, Orthopedics, Urology, Nursing, Infection Control, Wound Care, Biologics, ET, Sterilization, HOPPS, O.R, ICU, NICU, Trauma, Central/Sterile, Materials Management, C-Suite, Ambulatory Surgery Centers, Private Practice, Public Health

Experience

1. Chief Access Officer

   Octave

   Feb 2024 — Present · Charlotte, NC, US

   Executive Leader recruited to lay the foundation for patient and provider access to a revolutionary blood-based biomarker (\"MSDA\")+ advanced neuro MRI/AI (\"Insights\") technology for patients diagnosed with Multiple Sclerosis. Both proprietary technologies provide actionable information that monitor MS disease activity and progression; datasets that providers use to get MS patients on the right treatment at the right time to improve outcomes & to reduce unnecessary costs in the healthcare system. The company recently received a $10M grant from the Michael J. Fox Foundation to separately develop testing for Parkinson\'s disease. I will be working with our internal and external teams, Pharma and our Investors to develop and execute corporate market access strategies around these challenging neuro-degenerative diseases and to secure appropriate CPT coding, medical policy coverage, reimbursement & contracts - in addition to leading government affairs and legislative initiatives that drive accelerated company growth, profitability and Investor ROI. Thank you to my Investors and colleagues who led me to this wonderful mission.Please click link below for more information.

Education

• University of Memphis

  Bachelors, Marketing, Merchandising

  1984 — 1988

• Harding Academy

  High School, General Business

  1979 — 1984

Skills

• Product Launch
• Public Health
• Surgery
• Cardiology
• Medicine
• Icu
• Healthcare
• Neurology
• Medical Devices
• Market Development
• Biotechnology
• Managed Care
• Oncology
• Urology
• Wound Care
• Sterilization
• Orthopedic
• Hospitals
• Materials Management
• Biologics
• Capital Equipment
• Nursing